The FDA has released a draft guidance recommending the reclassification of full-field digital mammography systems from class III to class II. The agency is calling for public comment on the proposal through Aug. 28.
Published in Brief:
|Senior Director, Biostatistics||
|Associate - Food and Drug||
Keller and Heckman LLP
|Senior Paralegal - Research & Development, and Medical||